Deciphering this close interplay between ZNF217 and epigenetic processes, thus, sets the stage for considering epidrugs strategies, alone or in combination with conventional treatments, and holds potent therapeutic potential for the treatment of ZNF217-positive cancers. Here, ZNF217 is linked to cancer.